Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
Shanmugam M. Jeyakumar, Ayyalasomayajula Vajreswari
World Journal of Hepatology (2022) Vol. 14, Iss. 1, pp. 168-179
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Pharmacologic inhibition of lipogenesis for the treatment of NAFLD
William P. Esler, David E. Cohen
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 362-377
Open Access | Times Cited: 40
Rapid screening and sensing of stearoyl-CoA desaturase 1 (SCD1) inhibitors from ginger and their efficacy in ameliorating non-alcoholic fatty liver disease
Xin Zeng, Shang Wang, Ze Peng, et al.
Journal of Food Measurement & Characterization (2024) Vol. 18, Iss. 8, pp. 6843-6857
Open Access | Times Cited: 22
Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity
María Ángeles Núñez‐Sánchez, María Antonia Martínez‐Sánchez, José Ignacio Martínez‐Montoro, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 7, pp. 1781-1792
Open Access | Times Cited: 9
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease
Manuel Soto‐Catalán, Lucas Opazo-Ríos, Hernán Quiceno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2961-2961
Open Access | Times Cited: 9
Passion Fruit Seed Extract Attenuates Hepatic Steatosis in Oleic Acid-Treated HepG2 Cells through Modulation of ERK1/2 and Akt Signaling Pathways
Furoida Moolsup, Wiwit Suttithumsatid, Wanwipha Woonnoi, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Fatty Acid Profile and Genetic Variants of Proteins Involved in Fatty Acid Metabolism Could Be Considered as Disease Predictor
R. Chaaba, Aicha Bouaziz, Asma Ben Amor, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 979-979
Open Access | Times Cited: 15
A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 Regulation
Hélène Le Mentec, Emmanuelle Monniez, Antoine Legrand, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3942-3942
Open Access | Times Cited: 13
The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights
Zhuo Huang, Qinyan Yao, Shuang Ma, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
Lara Mastnak, Rok Herman, Simona Ferjan, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2124-2124
Open Access | Times Cited: 11
Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress
Ziming Mao, Xiaowen Ma, Yu Jing, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 10
Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation
Danqing Wang, Miao Zhang, Jiaojiao Xu, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3121-3121
Open Access | Times Cited: 9
Emerging pharmacological treatment options for MAFLD
Ángela Rojas, Carmen Lara‐Romero, Rocío Múñoz‐Hernández, et al.
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 14
An aqueous olive leaf extract (OLE) ameliorates parameters of oxidative stress associated with lipid accumulation and induces lipophagy in human hepatic cells
Stefano Tacconi, S. Longo, Flora Guerra, et al.
Food & Function (2023) Vol. 14, Iss. 12, pp. 5805-5819
Open Access | Times Cited: 8
Associations of altered hepatic gene expression in American lifestyle-induced obesity syndrome diet-fed mice with metabolic changes during NAFLD development and progression
Valeria Iannone, Johnson Lok, Ambrin Farizah Babu, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 115, pp. 109307-109307
Open Access | Times Cited: 7
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
И. В. Холоденко, Р. В. Холоденко, K. N. Yarygin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15212-15212
Open Access | Times Cited: 7
Expanding diagnostic and therapeutic horizons for MASH: Comparison of the latest and conventional therapeutic approaches
Georgia Anastasiou, Konstantinos Stefanakis, Michael A. Hill, et al.
Metabolism (2024), pp. 156044-156044
Closed Access | Times Cited: 2
Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2466-2466
Open Access | Times Cited: 5
Lipogenic stearoyl-CoA desaturase-1 (SCD1) targeted virtual screening for chemical inhibitors: molecular docking / dynamics simulation and in vitro assessment of anti-NAFLD efficacy
Sonakshi Puri, Shivani Kirad, Mohammed Muzaffar-Ur-Rehman, et al.
RSC Advances (2024) Vol. 14, Iss. 43, pp. 31797-31808
Open Access | Times Cited: 1
Trajectory Inference for Unraveling Dynamic Biological Processes from Raman Spectral Data
Nicolas Goffin, Émilie Buache, Céline Charpentier, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 9, pp. 4395-4403
Closed Access | Times Cited: 4
Mechanism of SCD Participation in Lipid Droplet-Mediated Steroidogenesis in Goose Granulosa Cells
Xin Yuan, Ibn Iddriss Abdul-Rahman, Shenqiang Hu, et al.
Genes (2022) Vol. 13, Iss. 9, pp. 1516-1516
Open Access | Times Cited: 7
A Single Nucleotide Polymorphism (rs3811792) Affecting Human SCD5 Promoter Activity Is Associated with Diabetes Mellitus
Veronika Zámbó, Gabriella Orosz, Luca Szabó, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1784-1784
Open Access | Times Cited: 5
Genetic Variants in WNT16 and PKD2L1 Locus Affect Heel Ultrasound Bone Stiffness: Analyses from the General Population and Patients Evaluated for Osteoporosis
Angelique Kragl, Anke Hannemann, Matthias Nauck, et al.
Calcified Tissue International (2023) Vol. 113, Iss. 5, pp. 540-551
Open Access | Times Cited: 2
Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease
Qianren Zhang, Yan Dong, Jian‐Gao Fan
Hepatobiliary & pancreatic diseases international (2023)
Closed Access | Times Cited: 2
Advances and Emerging Therapies in the Treatment of Non-alcoholic Steatohepatitis
Paul Brennan, John Dillon, Rory J. McCrimmon
touchREVIEWS in Endocrinology (2022) Vol. 18, Iss. 2, pp. 148-148
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top